Aggregating behavior of phenolic compounds - A source of false bioassay results?

Molecules

Volumn 17, Issue 9, 2012, Pages 10774-10790

  Pohjala, Leena ^a,b   Tammela, Päivi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

Aggregation; Bioactivity screening; Dynamic light scattering; Flavonoid; Nonspecific inhibition; Promiscuous binder; Quercetin; Rhamnetin

Indexed keywords

DRUG DERIVATIVE; PHENOL DERIVATIVE; QUERCETIN; RHAMNETIN;

ARTICLE; BIOASSAY; CHEMISTRY; METABOLISM; REPRODUCIBILITY;

BIOLOGICAL ASSAY; PHENOLS; QUERCETIN; REPRODUCIBILITY OF RESULTS;

EID: 84866914982     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules170910774     Document Type: Article

References (28)

1. Tsao, R. Chemistry and biochemistry of dietary polyphenols. Nutrients 2010, 2, 1231-1246.
2. Yao, L.H.; Jiang, Y.M.; Shi, J.; Tomás-Barberán, F.A.; Datta, N.; Singanuson, R.; Chen, S.S. Flavonoids in food and their health benefits. Plant Foods Hum. Nutr. 2004, 59, 113-122.
3. Hertog, M.G.L.; Feskens, E.J.M.; Hollman, P.C.H.; Katan, M.B.; Kromhout, D. Dietary antioxidant flavonoids and the risk of coronary artery disease. The Zutphen elderly study. Lancet 1993, 342, 1007-1011.
4. Hertog, M.G.L.; Kromhout, D.; Aravanis, C.; Blackburn, H.; Buzina, R.; Fidanza, F.; Giampaoli, S.; Jansen, A.; Menotti, A.; Nedeljkovic, S.; et al. Flavonoids intake and long-term risk of coronary heart disease and cancer in seven countries study. J. Arch. Intern. Med. 1995, 155, 381-386.
5. Butler, M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod. 2004, 67, 2141-2153.
6. Baker, D.D.; Chu, M.; Oza, U.; Rajgarhia, V. The value of natural products to future pharmaceutical discovery. Nat. Prod. Res. 2007, 24, 1225-1244.
7. Li, J.W.; Vederas, J.C. Drug discovery and natural products: End of an era or an endless frontier? Science 2009, 325, 161-165.
8. Shoichet, B.K. Screening in a spirit haunted world. Drug Disc. Today 2006, 11, 607-615.
9. McGovern, S.L.; Caselli, E.; Grigoriedd, N.; Shoichet, B.K. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J. Med. Chem. 2002, 45, 1712-1722.
10. McGovern, S.L.; Helfand, B.T.; Feng, B.; Shoichet, B.K. A specific mechanism of nonspecific inhibition. J. Med. Chem. 2003, 46, 4265-4272.
11. McGovern, S.L.; Shoichet, B.K. Kinase inhibitors: Not just for kinases anymore. J. Med. Chem. 2003, 46, 1478-1483.
12. Rishton, G.M. Nonleadlikeness and leadlikeness in biochemical screening. Drug Disc. Today 2003, 8, 86-96.
13. Coan, K.E.; Shoichet, B.K. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors. J. Am. Chem. Soc. 2008, 130, 9606-9612.
14. Feng, B.Y.; Shoichet, B.K. Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures. J. Med. Chem. 2006, 49, 2151-2154.
15. Frenkel, Y.V.; Clark, A.D.; Das, K.; Wang, Y.H.; Lewi, P.J.; Janssen, P.A.; Arnold, E. Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance for oral bioavailability. J. Med. Chem. 2005, 48, 1974-1983.
16. Ross, J.A.; Kasum, C.M. Dietary flavonoids: Bioavailability, Metabolic affects and safety. Annu. Rev. Nutr. 2002, 22, 19-34.
17. Feng, B.Y.; Simeonov, A.; Jadhav, A.; Babogiu, K.; Inglese, J.; Shoichet, B.K. A high-throughput screen for aggregation-based inhibition in a large chemical library. J. Med. Chem. 2007, 49, 2385-2390.
18. Feng, B.Y.; Shoichet, B.K. A detergent-based assay for the detection of promiscuous inhibitors. Nat. Protoc. 2006, 1, 550-553.
19. Babaogui, K.; Simeonov, A.; Irwin, J.J.; Nelson, M.E.; Feng, B.; Thomas, C.J.; Cancian, L.; Costi, M.P.; Maltby, D.A.; Jadhav, A.; et al. Comprehensive mechanistic analysis of hits from hifg-throughput and docking screens against beta-lactamase. J. Med. Chem. 2008, 51, 2502-2511.
20. The PubChem Project. Available online: http://pubchem.ncbi.nlm.nih.gov (accessed on 11 January 2012).
21. Wang, Y.; Xiao, J.; Suzek, T.O.; Zhang, J.; Wang, J.; Zhou, Z., Han, L.; Karapetyan, K.; Dracheva, S.; Shoemaker, B.A.; et al. PubChem BioAssays database. Nucleic Acids Res. 2012, 40, 400-412.
22. Pohjala, L.; Utt, A.; Varjak, M.; Lulla, A.; Merits, A.; Ahola, T.; Tammela, P. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One 2011, 6, e28923.
23. Bakhtiarova, A.; Taslimi, P.; Elliman, S.J.; Kosinski, P.A.; Hubbard, B.; Kavana, M.; Kemp, D.M.; Resveratrol inhibits firefly luciferase. Biochem. Biophys. Res. Comm. 2006, 351, 481-484.
24. Di, L.; Kerns, E.H. Profiling drug-like properties in discovery process. Curr. Opin. Chem. Biol. 2003, 7, 402-408.
25. Baell, J.B.; Holloway, G.A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem. 2010, 53, 2719-2740.
26. Seidler, J.; McGovern, S.L.; Doman, T.N.; Shoichet, B.K. Identification and prediction of promiscuous aggregating inhibitors among known drugs. J. Med. Chem. 2003, 46, 4477-4486.
27. Riihimäki-Lampén, L.H.; Vainio, M.J.; Vahermo, M.; Pohjala, L.L.; Heikura, J.M.; Valkonen, K.H.; Virtanen, V.T.; Yli-Kauhaluoma, J.T.; Vuorela, P.M. The binding of synthetic retinoids to lipocalin beta-lactoglobulin. J. Med. Chem. 2010, 53, 514-518.
28. Pohjala, L.; Tammela, P.; Samanta S.K.; Yli-Kauhaluoma, J.; Vuorela, P. Assessing the data quality in predictive toxicology using a panel of cell lines and cytotoxicity assays. Anal. Biochem. 2007, 362, 221-228.